Recent Event Highlights: Talking to 3 major pharma cos for a JV: Suven Life, Suven Life gets 3 products patents in Japan, Trading strategies on 8 stocks that buzzed last week, Trading strategies on 8 stocks that buzzed last week, Trading strategies on 8 stocks that buzzed last week, Trading strategies on 8 stocks that buzzed last week, and 34 more...
Created by dipity on Aug 25, 2009
Last updated: 11/15/10 at 03:17 AM
Suven Life Sciences has no followers yet. Be the first one to follow.
Suven Life Sciences has secured two product patents, one each in Australia and Mexico. In an interview with CNBC-TV18's Latha Venkatesh and Reema Tendulkar, Venkat Jasti, CEO, Suven Life Sciences spoke on the company's business plans going forward.
Hyderabad-based biopharmaceutical company Suven Life Sciences Ltd said it secured two product patents from Japanese Patent Office for its new chemical entities which is for the treatment of disorders associated with neurodegenerative diseases.
In an interview with CNBC-TV18, Technical Analysts Mitesh Thacker of miteshthacker.com and Sajiv Dhawan of JV Capital Services, discuss various stocks, which were buzzing last week and advise how to trade them in the one ahead. PART5
In an interview with CNBC-TV18, Technical Analysts Mitesh Thacker of miteshthacker.com and Sajiv Dhawan of JV Capital Services, discuss various stocks, which were buzzing last week and advise how to trade them in the one ahead. PART4
In an interview with CNBC-TV18, Technical Analysts Mitesh Thacker of miteshthacker.com and Sajiv Dhawan of JV Capital Services, discuss various stocks, which were buzzing last week and advise how to trade them in the one ahead. PART3
In an interview with CNBC-TV18, Technical Analysts Mitesh Thacker of miteshthacker.com and Sajiv Dhawan of JV Capital Services, discuss various stocks, which were buzzing last week and advise how to trade them in the one ahead. PART2
In an interview with CNBC-TV18, Technical Analysts Mitesh Thacker of miteshthacker.com and Sajiv Dhawan of JV Capital Services, discuss various stocks, which were buzzing last week and advise how to trade them in the one ahead. PART1
Hold Suven Life Sciences, says Mitesh Thacker, Technical Analyst, miteshthacker.com.
In an interview with CNBC-TV18, Bino Pathiparampil, Vice President, IIFL Capital, spoke about his outlook for Sun-Taro saga and other pharamaceutical companies.
In an interview with CNBC-TV18, Venkat Jasti, Chief Executive Officer of Suven Life Sciences, spoke about his outlook for the company.
Anu Jain, Vice PresidentIIFL Private Wealth Management, India Infoline is bullish on Union Bank, JB Chemicals, Bajaj Steel, Bharati Shipyard and Bharti Airtel. She advises investors to buy into these stocks. PART2
Anu Jain, Vice PresidentIIFL Private Wealth Management, India Infoline is bullish on Union Bank, JB Chemicals, Bajaj Steel, Bharati Shipyard and Bharti Airtel. She advises investors to buy into these stocks. PART1
Sanjeev Agarwal, MD, Dynamixresearch.com is of the view that Suven Life Sciences has support at Rs 25-27.
Mitesh Thacker, Technical Analyst, miteshthacker.com is of the view that Suven Life Sciences can touch Rs 60.
In an interview with CNBC-TV18, Venkat Jasti, Chief Executive Officer of Suven Life Sciences, spoke about his outlook for the company.
In an interview with CNBC-TV18, Venkat Jasti, Managing Director of Suven Life Sciences, spoke about the companys results and his outlook for it.
Suven Life Sciences has target of Rs 35, says Technical Analyst, Ashwani Gujral.
In an interview with CNBC-TV18, Venkat Jasti, Managing Director of Suven Life Sciences, spoke about the companys fund raising plans.
Sudarshan Sukhani of Technical Trends is bullish on GE Shipping, Rain Commodities, Subros, Sterlite and Tech Mahindra. He advises investors to buy these stocks. PART2
Sudarshan Sukhani of Technical Trends is bullish on GE Shipping, Rain Commodities, Subros, Sterlite and Tech Mahindra. He advises investors to buy these stocks. PART1
Suven Life Sciences touches 52-week highMoneycontrol.comSuven Life Sciences has touched an intra day high of Rs 34.75 and an intra day low of Rs 32.50. At 10:03 am the share was quoting at Rs 34.75, up Rs 3.15, ...
http://news.google.com/news/url?fd=R&sa=T&url=http%3A%2F%2Fwww.moneycontrol.com%2Findia%2Fnews%2Fbuzzing-stocks%2Fsuven-life-sciences-touches-52-week-high%2F412770&usg=AFQjCNEM54Fgn6-FHYC_wIuDuh5zQ_MUAw
Sensex trades higher on positive global cuesMoneycontrol.comSuven Life Sciences surged 10%, after seeing 20% rally for last two days. Orchid Chemical was up 2%. Aptech, KPIT Cummins and Aftek were up 2.5-6%. ...
http://news.google.com/news/url?fd=R&sa=T&url=http%3A%2F%2Fwww.moneycontrol.com%2Findia%2Fnews%2Flocal-markets%2Fsensex-trades-higherpositive-global-cues%2F412768&usg=AFQjCNEI_K55U51T8JHPetestZ6ENgMoYA
Sensex lifeline: high beeps and pratfallsLivemintShares of Suven Life Sciences Ltd gained 20% on the National Stock Exchange on Tuesday. The Indian drug maker said four global pharmaceutical companies have ...
http://news.google.com/news/url?fd=R&sa=T&url=http%3A%2F%2Fwww.livemint.com%2F2009%2F08%2F26003000%2FSensex-lifeline-high-beeps-an.html&usg=AFQjCNFjD4jcgg2PCgS36zJXUTXk347YOw
Excerpt
...Aug. 25 The stock of Suven Life Sciences continued to climb on the bourses with higher volumes after the company informed the BSE that it is talking to four “global pharma majors” to outlicense an experimental molecule for treating Alzheimer’s disease and...
Source Info
Hindu Business Line
http://www.thehindubusinessline.com/2009/08/26/stories/2009082650461000.htm
Indian Stocks Advance as Monsoon Concern Eases; ITC GainsBloombergSuven Life Sciences Ltd. (SVLS IN) jumped 20 percent to 31.4 rupees. The Indian drugmaker surged after yesterday saying four global pharmaceutical companies ...and more »
http://news.google.com/news/url?fd=R&sa=T&url=http%3A%2F%2Fwww.bloomberg.com%2Fapps%2Fnews%3Fpid%3D20601091%26sid%3DalP7w4Xvvflg&usg=AFQjCNHfZTNLYFh9wFxn18-C_fl_uHbqAg
Indian Market Ends Higher For 4th Straight SessionRTT NewsSuven Life Sciences was locked at the 20% upper circuit limit on saying that it was in talks with four global pharmaceutical firms for outlicensing its ...and more »
http://news.google.com/news/url?fd=R&sa=T&url=http%3A%2F%2Fwww.rttnews.com%2FContent%2FAsianMtUpdates.aspx%3FNode%3DB3%26Id%3D1048764&usg=AFQjCNFdPi6b8F0cYFPXMqxiQ1xM7b45YA
Nifty shuts above 4650 levelsIndia Infoline.comShares of Suven Life Sciences were locked at 20% to Rs31.6 after the Chairman & CEO, Venkat Jasti said the company is in talks with four global Pharma ...Indian Market Ends Higher For 4th Straight SessionRTT NewsNifty positive amid volatility; broader indices outperformMoneycontrol.comNifty hits 4650; Unitech, Cairn, Tata Motor, ITC up 5-6%Moneycontrol.comIndia Infoline.com -Moneycontrol.comall 325 news articles »
http://news.google.com/news/url?fd=R&sa=T&url=http%3A%2F%2Fwww.indiainfoline.com%2Fnews%2Finnernews.asp%3FstoryId%3D112387%26lmn%3D1&usg=AFQjCNEjd0L2zFars4tzHCcJcytRybPkDA
Stocks to watch: HCL Tech, Lanco Infra, Ranbaxy, Bharti Airtel ...Economic TimesSuven Life Sciences is in talks with four global pharma majors, who are evincing keen interest about the possible out-licensing deals for SUVN-502, ...and more »
http://news.google.com/news/url?fd=R&sa=T&url=http%3A%2F%2Feconomictimes.indiatimes.com%2FViews%2FRecommendations%2FStocks-to-watch-HCL-Tech-Lanco-Infra-Ranbaxy-Bharti-Airtel-NTPC-Suven-Life-Sciences%2Farticleshow%2F4931372.cms&usg=AFQjCNHncCU68tSDBfOPPEMbXc0D5aoxHw
Suven Life Sciences in demand on Alzheimer drug dealEconomic TimesMUMBAI: Shares of Suven Life Sciences touched a 52-week high after the firm said it was in talks with four global pharmaceutical firms, which have shown an ...Suven Life up 20% on BSEHindu Business LineIndia Hot Stocks: Suven Life surges on outlicense deals talkReuters IndiaSuven Life Sciences in talks to outlicense Alzheimer's moleculeStock Market Todaydomain-B -Indopia -Moneycontrol.comall 11 news articles »
http://news.google.com/news/url?fd=R&sa=T&url=http%3A%2F%2Feconomictimes.indiatimes.com%2Fstocks-in-news-home%2FSuven-Life-Sciences-touches-52-week-high%2Farticleshow%2F4931662.cms&usg=AFQjCNFfwHhUQrAZOHoPHyvfF_WvGLm97Q
Nifty trades lower with volatility; Shanghai slips 4%Moneycontrol.comIn the smallcap space, Suven Life Sciences surged 16.51%. Oscar Investment, Madhucon Projects, Atul and Manappuram went up 9-10%. ...and more »
http://news.google.com/news/url?fd=R&sa=T&url=http%3A%2F%2Fwww.moneycontrol.com%2Findia%2Fnews%2Flocal-markets%2Fnifty-trades-lowervolatility-shanghai-slips-4%2F412603&usg=AFQjCNFTG49Ye77cAnfYeStL0s1ijIzxfA
Indian shares may fall after 3-day rallyReutersSuven Life Sciences Ltd (SUVP.BO) after it said late on Monday it was in talks with four global pharmaceutical firms, which have shown an interest in ...Indian shares fall 0.8 pct; ICICI, Infosys dropReuters Indiaall 5 news articles »
http://news.google.com/news/url?fd=R&sa=T&url=http%3A%2F%2Fwww.reuters.com%2Farticle%2FrbssFinancialServicesAndRealEstateNews%2FidUSBOM44034220090825&usg=AFQjCNEo38E_EkKPjhd3IY1qwaVYvm8yTQ
Sensex lifeline: high beeps and pratfallsLivemintShares of Suven Life Sciences Ltd soared 17% on the National Stock Exchange on Monday. The Indian drugmaker said four global pharmaceutical companies have ...and more »
http://news.google.com/news/url?fd=R&sa=T&url=http%3A%2F%2Fwww.livemint.com%2F2009%2F08%2F24222953%2FSensex-lifeline-high-beeps-an.html&usg=AFQjCNFAe7AH6rMWui6a1DzjXqruSaXcyQ
Thaindian.comNifty hits 4650; Unitech, Cairn, Tata Motor, ITC up 5-6%Moneycontrol.comSuven Life Sciences said they were in talks to outlicense Alzheimer's molecule; ten global pharma companies were interested in Alzheimer's molecule and was ...Sensex breaks 3-day rally, down 100 pts; Shanghai dips 5%Moneycontrol.comSensex weak on negative Asian cues; banks declineMoneycontrol.comall 257 news articles »
http://news.google.com/news/url?fd=R&sa=T&url=http%3A%2F%2Fwww.moneycontrol.com%2Findia%2Fnews%2Flocal-markets%2Fnifty-hits-4650-unitech-cairn-tata-motor-itc5-6%2F412486&usg=AFQjCNE-OyNSRyi_aA1TzoO49hGRu9gaiQ
To raise $20m: Suven Life SciencesMoneycontrol.comVenkat Jasti, MD, Suven Life Sciences, expects the first milestone from Eli Lilly deal in the January- March quarter. He says the company plans to raise USD ...
http://news.google.com/news/url?fd=R&sa=T&url=http%3A%2F%2Fwww.moneycontrol.com%2Findia%2Fnews%2Fbusiness%2Fto-raise-3620m-suven-life-sciences%2F411441&usg=AFQjCNFYv7VSrcwYD9GrwJ2Iz2Ih28COww
Suven Life to raise up to $20 m through equity placementSifyDrug firm Suven Life Sciences is looking to raise $20 million through debt and private equity placement for conducting phase II trial of its molecule ...
http://news.google.com/news/url?fd=R&sa=T&url=http%3A%2F%2Fsify.com%2Ffinance%2Fequity%2Ffullstory.php%3Fa%3Djilmxubgcda%26title%3DSuven_Life_to_raise_up_to_20_m_through_equity_placement%26cid%3D20753&usg=AFQjCNGdYovC19amow6tHm2L3J7AddZGjw
Excerpt
...firm Suven Life Sciences is looking to raise $20 million through debt and private equity placement for conducting phase II trial of its molecule indicated for the treatment of Alzheimer. "We are going to initiate phase II clinical trial for our molecule...
Source Info
Business Standard
Related Topics
http://feedproxy.google.com/~r/Business-Standard-News-Now/~3/_FOK_xlzcUQ/storypage_c.php
Excerpt
...Life Sciences Ltd’s net profit increased 36.6 per cent at Rs 2.18 crore in the first quarter ended June 30, 2009, compared with Rs 1.59 crore in the corresponding quarter of the previous financial year. The revenue of the Hyderabad-based company dipped marginally,...
Source Info
Hindu Business Line
Related Topics
http://www.thehindubusinessline.com/2009/07/30/stories/2009073051230200.htm
Excerpt
...Suven Life Sciences, the biopharmaceuticals contract research company, is planning to kick off a fund-raising road show in July to raise $20 million for research on its Alzheimer's drug candidate Suvn-502, which is set to enter phase-2a stage by December this...
Source Info
DNA India
http://www.dnaindia.com/report.asp?newsid=1251893
Excerpt
...drug discovery and development company Suven Life Sciences completed its Phase-I multiple ascending dose study of SUVN-502 in healthy volunteers. SUVN-502 is intended for treatment of Alzheimer's disease, Schizophrenia and other disorders of memory and cognition...
Source Info
Business Standard
http://feedproxy.google.com/~r/Business-Standard-News-Now/~3/_ZNFKclPoH8/storypage_c.php
Excerpt
...a former independent director of Satyam and former Cabinet secretary, has resigned from the board of Hyderabad-based Suven Life Sciences, citing personal reasons. Suven Life said Mr Prasad's resignation will be with effect from January 13. "He is resigning...
Source Info
Economic Times
http://economictimes.indiatimes.com/News/News-By-Industry/Healthcare--Biotech/Pharmaceuticals/Former-independent-director-of-Satyam-quits-Suven-Life-Sciences/rssarticleshow/3982476.cms
Excerpt
...of its new chemical entities (NCEs) either at the clinical stage or close to it, biopharmaceuticals research company Suven Life Sciences is exploring the possibility of monetising its intellectual property by hiving off the assets into a separate entity. This...
Source Info
Sify
http://sify.com/finance/fullstory.php?id=14635200
Excerpt
...thus showing confidence in Suvens drug discovery capabilities, Ramakrishna Nirogi, vice-president (drug discovery) of Suven Life Sciences said. Venkat Jasti, CEO of Suven Life Sciences, said the collaboration would leverage the Indian firms experience in small...
Source Info
Calcutta Telegraph
http://www.telegraphindia.com/1080313/jsp/business/story_9013974.jsp
Excerpt
...system disorders arena, thus showing the confidence in Suven's drug discovery capabilities," said Ramakrishna Nirogi, Vice President, Drug Discovery of Suven life Sciences. At 3:12 pm, Suven Life shares were up 7.98 per cent at Rs 37.90 on BSE. ...
Source Info
Economic Times
http://economictimes.indiatimes.com/News/News_By_Industry/Healthcare__Biotech/Healthcare/Suven_Life_Sciences_US_co_enter_deal_on_pre-clinical_research/rssarticleshow/2858387.cms
Excerpt
...Suven Life Sciences has signed a second agreement with US-based Eli Lilly and Company to collaborate on pre-clinical research of molecules in the therapeutic area of central nervous system (CNS) disorders. Suven will receive research funding as well as potential...
Source Info
Business Standard
http://feeds.feedburner.com/~r/Business-Standard-News-Now/~3/250024792/storypage_c.php
Excerpt
...The US Patent and Trademark Office ( PTO) has granted Suven Life Sciences a product patent. The granted claims of the patent include the class of selective serotonin receptor affinity compounds discovered by Suven and are being developed as therapeutic agents. According...
Source Info
Business Standard
http://feeds.feedburner.com/~r/Business-Standard-News-Now/~3/221468167/storypage_c.php
Excerpt
...MUMBAI: Suven Life Sciences has received its first product patent from the US Patent Office. The granted claims of the patent include the class of selective Serotonin receptor affinity compounds discovered by Suven and being developed as therapeutic agents. ...
Source Info
Economic Times
http://economictimes.indiatimes.com/News/News_By_Industry/Healthcare__Biotech/Pharmaceuticals/Suven_Life_Sciences_receives_first_US_product_patent/rssarticleshow/2654546.cms
Excerpt
...like Alzheimer's, Schizophrenia, Depression, Cognitive disorders, Sleep, Neurodegeneration and Obesity through CNS targets. Suven Life Sciences is a Hyderabad based Life Sciences Company a Collaborative Research Partner (CRP) since 2006 in Drug Discovery for...
Source Info
Drugs.com
http://feeds.drugs.com/~r/Drugscom-ClinicalTrials/~3/180227574/suven-sciences-presenting-pre-clinical-data-their-nces-society-neuroscience-annual-meeting-sfn-2007-2577.html
Excerpt
...Life Sciences Ltd (SLSL) announced that it has received NABL (National Accreditation Board for Testing and Calibration Laboratories) certificate from the Department of Science & Technology, India, for its biopharmaceutical research lab in Hyderabad with the...
Source Info
Hindu Business Line
http://www.thehindubusinessline.com/2006/09/21/stories/2006092103050200.htm
Excerpt
...Hyderabad-based Suven Life Sciences on Tuesday announced the signing of an agreement with Eli Lilly and Company, a U.S.-based global pharmaceutical firm, to collaborate on the pre-clinical research of molecules in the therapeutic area of central nervous system...
Source Info
The Hindu
http://www.thehindu.com/2006/08/30/stories/2006083003581820.htm
Update Sources